Posted on 3/14/19
PharmMD Changes Company Name to AdhereHealth
Reflects vision of better health through medication adherence by resolving social determinants through disruptive technologies, engagement services and home-delivered pharmacy PharmMD™, a leading healthcare technology company . . .
Posted on 3/14/19
Progenics Asserts Ownership of PSMA-617 Intellectual Property, Including Composition of Matter Patent
NEW YORK, March 14, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), an oncology company focused on the development and commercialization of innovative targeted medicines and . . .
Posted on 3/14/19
Onkos Surgical Announces Partnership with Promimic AB
Onkos Surgical, Inc. announced today that it has partnered with Promimic AB, the world's leading innovator in nano surface modification, to commercialize Promimic's proprietary Hydroxyapatite (HA) . . .
Posted on 3/14/19
Axsome Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update
NEW YORK, March 14, 2019 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous . . .
Posted on 3/14/19
ContraFect Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update
YONKERS, N.Y., March 14, 2019 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of novel, differentiated biologic therapeutics . . .
Posted on 3/14/19
Pfizer: This Biotech Blue-Chip Offers Market-Beating Total Return Potential
SummaryPfizer is a Dividend Challenger that has raised its dividend each year since 2010 and was actually a Dividend Aristocrat before a dividend cut during the . . .
Posted on 3/13/19
Hoth Therapeutics Enters into Commercial Licensing Agreement with University of Maryland, Baltimore and Isoprene Pharmaceuticals
Hoth Therapeutics, Inc. (NASDAQ: HOTH), a development-stage biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis–also known as eczema–as . . .
Posted on 3/13/19
Merck GHIF Leads $40M Series D For TriNetX
TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE)
Posted on 3/13/19
Why Johnson & Johnson Is Still An Attractive Investment
SummaryJohnson & Johnson has steadily performed during every economic cycle.The company is one of two with a AAA credit rating.Johnson & Johnson is finding ways to . . .
Posted on 3/12/19
Amneal Announces Launch of Rivastigmine Transdermal System
Amneal Pharmaceuticals, Inc. (NYSE: AMRX), today announced that it has launched its generic version of Exelon Patch (Rivastigmine Transdermal System), 4.6 mg/24 hours, 9.5 mg/24 hours, . . .
Posted on 3/12/19
Fidia Pharma USA Announces Expansion into Regenerative Medicine Markets with Launch of NuDYN
FLORHAM PARK, N.J.--(BUSINESS WIRE)--Fidia, a world leader in the research, development, and manufacturing of hyaluronic acid (HA)-based products, is introducing NuDYN, its first product in the . . .
Posted on 3/12/19
Advaxis Reports First Quarter Fiscal 2019 Financial Results and Provides Clinical Pipeline Update
PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis, Inc. (NASDAQ: ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today announced an update on its . . .
Posted on 3/12/19
J&J's Stelara Shows Positive Action In Late-Stage UC Study
New data from a Phase 3 clinical trial, UNIFI, evaluating Johnson & Johnson (NYSE:JNJ) unit Janssen Pharmaceutical's STELARA (ustekinumab) for the maintenance treatment of adults with . . .
Posted on 3/11/19
Bridge Medicines Enters Agreement with Weill Cornell Medicine
Bridge Medicines announced today an agreement with Weill Cornell Medicine to develop a novel sphingosine 1-phosphate (S1P) receptor modulator. This small molecule program originated in the . . .
Posted on 3/11/19
Better Buy: Abbott Laboratories vs. Johnson & Johnson
You won't find many if any blue-chip healthcare stocks that are "bluer" than Abbott Laboratories (NYSE:ABT) and Johnson & Johnson (NYSE:JNJ). Both companies have been around . . .
Posted on 3/11/19
Johnson & Johnson: Brace For Impact
SummaryA number of its major drugs are facing difficulty as competition is kicking in both nationally and internationally.Pricing pressure resulting from both the administration and competition . . .
Posted on 3/8/19
Johnson & Johnson: Brace For Impact
SummaryA number of its major drugs are facing difficulty as competition is kicking in both nationally and internationally.Pricing pressure resulting from both the administration and competition . . .
Posted on 3/8/19
Celgene-Bristol: Deal Or No Deal?
Summary Large BMY shareholders are starting to oppose its acquisition of CELG. The uncertainty of whether the deal will go through or not is driving the . . .
Posted on 3/8/19
2 Biotech Stocks With Major Incoming Catalysts
The end of the first quarter is just a few weeks away and more than a few biotechs still haven't delivered the important clinical trial results . . .
Posted on 3/8/19
Quest Diagnostics Prices $500 Million of Senior Notes
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today the pricing of a public offering of $500 million aggregate principal . . .
Posted on 3/8/19
Celldex Provides Corporate Update
HAMPTON, N.J., March 07, 2019 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported business and financial highlights for the fourth quarter and year ended December . . .
Posted on 3/7/19
American Medical & Dental Supplies Announces the Launch of Its New Web Site
Today, American Medical & Dental Supplies Inc., more commonly known as DDS Dental Supplies, announced immediate availability of their new website, allowing the public to search . . .
Posted on 3/7/19
Carestream Health to Sell Its Healthcare IT Business to Philips
ROCHESTER, N.Y.--(BUSINESS WIRE)--Carestream Health has signed an agreement with Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, to sell its healthcare information . . .
Posted on 3/6/19
Bristol-Myers Squibb Files Investor Presentation and Board of Directors Sends Letter to Shareholders
EW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) today filed an investor presentation with the Securities and Exchange Commission (SEC), and the Board of Directors sent an open . . .
Posted on 3/6/19
Opal Wealth Advisors’ Jesse Giordano Named to Forbes 2019 Best-in-State Wealth Advisors List in New York
JERICHO, N.Y.--(BUSINESS WIRE)--Opal Wealth Advisors, a registered investment advisory firm, today announced that Jesse Giordano, CFP, co-founder and principal, has been recognized as a 2019 Best-In-State . . .

